Trump administration: Drugmakers that hiked prices may create 'tipping point'

President Donald Trump
The Trump administration said Monday it is closely watching reports of drug increases. (The White House)

The secretary of HHS had a direct message on Monday for the pharmaceutical companies that have hiked the prices of their products in recent months: The president sees you. 

Speaking at an event hosted by the 340B Coalition, he alluded to a tweet earlier in the day from the commander-in-chief specifically calling out drug giant Pfizer and other drug companies for hiking their prices in recent months.

Pfizer hiked prices on about 40 drugs as of July 1, FiercePharma reported

Innovation Awards

Submit your nominations for the FierceHealthcare Innovation Awards

The FierceHealthcare Innovation Awards showcases outstanding innovation that is driving improvements and transforming the industry. Our expert panel of judges will determine which companies demonstrate innovative solutions that have the greatest potential to save money, engage patients, or revolutionize the industry. Deadline for submissions is this Friday, October 18th.

Suggested Articles

Genealogy company Ancestry is expanding into genetic health testing, ramping up competition with 23andMe.

Oscar Health will appeal a judge’s decision to toss its lawsuit against Blue Cross and Blue Shield of Florida over insurance broker agreements.

Physician-led ACOs generated nearly seven times more savings in 2018 than ACOs led by hospitals, a new analysis finds.